May 19 (Reuters) - Beleagured Canadian drugmaker Valeant
Pharmaceuticals International Inc VRX.TO VRX.N said it
received a notice of default from bondholders for the delay in
filing its quarterly report.
The Laval, Quebec-based company said it can avert default by
filing the report by July 18.
Last week, the company said it expected to file its
first-quarter report with U.S. and Canadian regulators on or
before June 10, ahead of a July 31 deadline, and reiterated its
first-quarter forecasts.